help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roti, E.
Right arrow Articles by Braverman, L. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roti, E.
Right arrow Articles by Braverman, L. E.

Journal of Clinical Endocrinology & Metabolism, Vol 75, 1273-1277, Copyright © 1992 by Endocrine Society

ARTICLES

Iodine-induced subclinical hypothyroidism in euthyroid subjects with a previous episode of amiodarone-induced thyrotoxicosis

E Roti, R Minelli, E Gardini, L Bianconi, G Gavaruzzi, G Ugolotti, TM Neri and LE Braverman
Centro per lo Studio, Prevenzione, Diagnosi e Cura delle Tireopatie, Universita di Parma, Italy.

Amiodarone-induced thyrotoxicosis (AIT) occurs most frequently in patients with underlying thyroid disease and is generally believed to be due to the iodine contamination of amiodarone and iodine released by the metabolism of the drug. We and others have suggested that the thyrotoxicosis may also be secondary to amiodarone-induced thyroiditis. To further determine the etiology of AIT, we administered large doses of iodides [10 drops saturated solution of potassium iodide (SSKI) daily] to 10 euthyroid patients long after an episode of AIT believed to be due at least in part to amiodarone-induced thyroiditis. Six of these 10 patients had an abnormal iodide-perchlorate discharge test before SSKI administration, indicating a subtle defect in the thyroidal organification of iodide. During SSKI administration, 6 patients developed marked iodine-induced basal and/or TRH-stimulated serum TSH elevations, 2 had suppressed basal and TRH-stimulated TSH values, and 2 had normal TSH responses compared to SSKI-treated euthyroid subjects with no history of amiodarone ingestion or thyroid disease. Serum T4 and T3 concentrations remained normal and unchanged during SSKI administration in both the AIT patients and control subjects. These results strongly suggest that excess iodine may not be the cause of the hyperthyroidism associated with amiodarone therapy, especially in those patients with probable amiodarone-induced thyroiditis. Furthermore, like patients with a previous history of subacute thyroiditis and postpartum thyroiditis, the present results suggest that some patients with a previous history of AIT may be at risk to develop hypothyroidism when given excess iodine.


This article has been cited by other articles:


Home page
 J. Clin. Endocrinol. Metab.Home page
I. J. Chopra and K. Baber
Use of Oral Cholecystographic Agents in the Treatment of Amiodarone-Induced Hyperthyroidism
J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4707 - 4710.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
E. Martino, L. Bartalena, F. Bogazzi, and L. E. Braverman
The Effects of Amiodarone on the Thyroid
Endocr. Rev., April 1, 2001; 22(2): 240 - 254.
[Abstract] [Full Text]

Home page
 Pharmacol. Rev.Home page
J. Wolff
Perchlorate and the Thyroid Gland
Pharmacol. Rev., March 1, 1998; 50(1): 89 - 106.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1992 by The Endocrine Society